Investigating molecular machines that modify macromolecules in diseases.
Structural and Functional Studies of Molecular Machines Involved in Chemical Modifications of Macromolecules
This study is looking at tiny machines in our cells that change important molecules, which can help us understand how these changes are linked to diseases like cancer and brain disorders, with the hope of finding new treatments for patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-10880606 on NIH RePORTER |
What this research studies
This research explores the structural and functional roles of molecular machines that chemically modify macromolecules, which are crucial for various biological processes. By studying systems like the p97 related ubiquitination and Vault related ADP-ribosylation, the research aims to understand how these modifications affect diseases such as cancers and neurodegenerative disorders. The approach involves advanced structural biology techniques and protein engineering to uncover the mechanisms behind these modifications and their implications in disease. Patients may benefit from new therapeutic strategies developed from this understanding.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with cancers or neurodegenerative disorders linked to misregulated chemical modifications.
Not a fit: Patients with conditions unrelated to chemical modifications of macromolecules may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative treatments for cancers and neurodegenerative diseases by targeting the molecular machines involved in chemical modifications.
How similar studies have performed: Previous research has shown promise in understanding molecular machines in disease contexts, suggesting potential for success in this area.
Where this research is happening
Chicago, United States
- University of Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Zhao, Minglei — University of Chicago
- Study coordinator: Zhao, Minglei
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.